1. Home
  2. GDS vs PBH Comparison

GDS vs PBH Comparison

Compare GDS & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDS
  • PBH
  • Stock Information
  • Founded
  • GDS 2001
  • PBH 1996
  • Country
  • GDS China
  • PBH United States
  • Employees
  • GDS N/A
  • PBH N/A
  • Industry
  • GDS Computer Software: Programming Data Processing
  • PBH Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDS Technology
  • PBH Health Care
  • Exchange
  • GDS Nasdaq
  • PBH Nasdaq
  • Market Cap
  • GDS 4.9B
  • PBH 4.1B
  • IPO Year
  • GDS 2016
  • PBH 2005
  • Fundamental
  • Price
  • GDS $25.45
  • PBH $87.25
  • Analyst Decision
  • GDS Strong Buy
  • PBH Buy
  • Analyst Count
  • GDS 5
  • PBH 5
  • Target Price
  • GDS $39.48
  • PBH $94.00
  • AVG Volume (30 Days)
  • GDS 1.9M
  • PBH 351.3K
  • Earning Date
  • GDS 05-20-2025
  • PBH 05-08-2025
  • Dividend Yield
  • GDS N/A
  • PBH N/A
  • EPS Growth
  • GDS N/A
  • PBH 2.88
  • EPS
  • GDS 2.49
  • PBH 4.29
  • Revenue
  • GDS $1,414,156,264.00
  • PBH $1,137,762,000.00
  • Revenue This Year
  • GDS $15.11
  • PBH $1.48
  • Revenue Next Year
  • GDS $13.47
  • PBH $2.28
  • P/E Ratio
  • GDS $11.30
  • PBH $20.29
  • Revenue Growth
  • GDS 5.52
  • PBH 1.10
  • 52 Week Low
  • GDS $6.11
  • PBH $62.35
  • 52 Week High
  • GDS $52.50
  • PBH $90.04
  • Technical
  • Relative Strength Index (RSI)
  • GDS 50.76
  • PBH 63.14
  • Support Level
  • GDS $25.62
  • PBH $80.62
  • Resistance Level
  • GDS $28.24
  • PBH $84.90
  • Average True Range (ATR)
  • GDS 1.15
  • PBH 2.16
  • MACD
  • GDS 0.60
  • PBH 0.75
  • Stochastic Oscillator
  • GDS 51.65
  • PBH 92.23

About GDS GDS Holdings Limited ADS

GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. It has aggressively raised capital over the past four years for expansion. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Share on Social Networks: